Today, one of my dearest friends, Dr. Meghan Nadeau, was honored by the Puget Sound Business Journal as a 40 under 40 award recipient. She was selected for her dedication to caring for women with hereditary breast cancer. Exemplified by her contribution, as one of the co-founders, to Jane.
What is Jane?
Well as the other co-founder, I can fill you in on some of the details…After I completed my fellowship at UCSF, I began practicing in Seattle, WA as a breast surgical oncologist. I quickly noticed a very concerning pattern. I was caring for numerous young woman with breast cancer. Some in their early 20s. Often with advanced and aggressive forms of breast cancer. Sadly, this is not that uncommon. I cared for many young breast cancer patients in San Francisco. Although breast cancer is truly a disease that most commonly occurs in older women, it CAN affect women in their 20s and 30s, well before the typical age when women begin annual screening mammograms. So what was so concerning? Well…nearly EVERY young women I cared for had multiple “red flags” that should have been identified prior to her breast cancer diagnosis. I was counseling these young women about genetic risk, submitting a sample for genetic testing, and identifying a genetic mutation (such as BRCA1) after they had already been diagnosed with breast cancer. The healthcare system had failed these young women. If these “red flags” had been identified prior to their breast cancer diagnosis, perhaps these women could have made an informed choice about their healthcare. Specifically, about their breast health. I could not continue caring for these young breast cancer patients without doing something about this blindspot in the healthcare system.
Breast cancer remains the most common cancer diagnosed in women and as I have already mentioned, it is most commonly diagnosed in older women. That is why for years and years the recommendation for breast cancer screening was to begin annual screening mammograms at age 40. But what about the uncommon diagnosis of breast cancer in young women? Well, we (the collective medical community) are supposed to notice the occasional “red flag” in a young woman’s family history and then appropriately refer her for genetic testing. Seems reasonable.
I assumed (as I’m sure most of you do too) that young women with an increased risk of breast cancer are being appropriately screened and offered genetic testing when indicated. I trusted the “system” just like all of my young patients had.
The system is broken.
I could go on and on about all the various reasons the system isn’t working, suffice to say, trust me, it is broken. I have tried to fix it, but I assure you, it doesn’t want to be fixed. At least not anytime soon.
Jane is our solution to this problem.
Rather than fix a broken system we are abandoning the system. We are on a mission to put the knowledge and tools in the hands of those who stand to benefit the most, you! We want to empower every women to take control of her breast health. We want every woman to have access to understanding her own unique, personalized breast cancer risk. Every women should have the option to be tested for genetic risk.
This is just the beginning but our little start-up, Jane, has BIG plans!